Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 230

Similar articles for PubMed (Select 1919637)

1.

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.

Reece DE, Barnett MJ, Connors JM, Fairey RN, Fay JW, Greer JP, Herzig GP, Herzig RH, Klingemann HG, LeMaistre CF, et al.

J Clin Oncol. 1991 Oct;9(10):1871-9. Erratum in: J Clin Oncol 1992 Jan;10(1):170.

PMID:
1919637
2.

Improved outcomes after autologous bone marrow transplantation for children with relapsed or refractory Hodgkin lymphoma: twenty years experience at a single institution.

Garfin PM, Link MP, Donaldson SS, Advani RH, Luna-Fineman S, Kharbanda S, Porteus M, Weinberg KI, Agarwal-Hashmi R.

Biol Blood Marrow Transplant. 2015 Feb;21(2):326-34. doi: 10.1016/j.bbmt.2014.10.020. Epub 2014 Oct 29.

PMID:
25445024
3.

Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone Lymphoma.

Schmidt-Tanguy A, Houot R, Lissandre S, Abgrall JF, Casassus P, Rodon P, Desablens B, Marolleau JP, Garidi R, Lamy T, Moles-Moreau MP, Damaj G.

Adv Hematol. 2014;2014:512508. doi: 10.1155/2014/512508. Epub 2014 Mar 2.

4.

Esophageal lesions in myeloproliferative neoplasms.

Sawada T, Adachi Y, Ishii Y, Yasui H, Arimura Y, Endo T.

Endoscopy. 2012;44 Suppl 2 UCTN:E173-4. doi: 10.1055/s-0031-1291754. Epub 2012 May 23. No abstract available.

PMID:
22622728
5.

[Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].

Adam Z, Rehák Z, Koukalová R, Szturz P, Krejčí M, Pour L, Zahradová L, Moulis M, Kodet R, Nebeský T, Brejcha M, Adamová Z, Hájek R, Mayer J.

Vnitr Lek. 2012 Jan;58(1):62-71. Czech.

PMID:
22448704
6.

BCNU-associated pneumonitis: portrait of a toxicity.

Till BG, Madtes DK.

Leuk Lymphoma. 2012 Jun;53(6):1019-20. doi: 10.3109/10428194.2011.654341. Epub 2012 Jan 31. No abstract available.

PMID:
22220936
7.

Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.

Lane AA, Armand P, Feng Y, Neuberg DS, Abramson JS, Brown JR, Fisher DC, LaCasce AS, Jacobsen ED, McAfee SL, Spitzer TR, Freedman AS, Chen YB.

Leuk Lymphoma. 2012 Jun;53(6):1130-6. doi: 10.3109/10428194.2011.645208. Epub 2012 Jan 3.

8.

High-dose chemotherapy with bone marrow transplantation for advanced colorectal cancer.

Codaccipisanelli G, Seminara P, Gargano L, Accordino M, Sbaffi E, Bonaiuti V, Rossetti R, Franchi F.

Int J Oncol. 1997 Jul;11(1):25-9.

PMID:
21528176
9.

JAAD grand rounds quiz*: Dusky intertriginous plaques and acral erythema after bone marrow transplant.

Lane N, Donaldson MR, Stetson CL, Smith JL.

J Am Acad Dermatol. 2010 Jul;63(1):175-7. doi: 10.1016/j.jaad.2009.10.015.

PMID:
20542188
10.

Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.

Dunkel IJ, Khakoo Y, Kernan NA, Gershon T, Gilheeney S, Lyden DC, Wolden SL, Orjuela M, Gardner SL, Abramson DH.

Pediatr Blood Cancer. 2010 Jul 15;55(1):55-9. doi: 10.1002/pbc.22504.

PMID:
20486171
11.

Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist treatment.

Blumenfeld Z, Zuckerman T.

Oncologist. 2010;15(1):59-60. doi: 10.1634/theoncologist.2009-0269. Epub 2010 Jan 12. No abstract available.

12.

Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group.

Finlay JL, Dhall G, Boyett JM, Dunkel IJ, Gardner SL, Goldman S, Yates AJ, Rosenblum MK, Stanley P, Zimmerman RA, Wallace D, Pollack IF, Packer RJ; Children's Cancer Group.

Pediatr Blood Cancer. 2008 Dec;51(6):806-11. doi: 10.1002/pbc.21732.

13.

Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma.

Benekli M, Smiley SL, Younis T, Czuczman MS, Hernandez-Ilizaliturri F, Bambach B, Battiwalla M, Padmanabhan S, McCarthy PL Jr, Hahn T.

Bone Marrow Transplant. 2008 Apr;41(7):613-9. Epub 2007 Dec 10.

PMID:
18071290
14.
15.

Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.

Majhail NS, Weisdorf DJ, Defor TE, Miller JS, McGlave PB, Slungaard A, Arora M, Ramsay NK, Orchard PJ, MacMillan ML, Burns LJ.

Biol Blood Marrow Transplant. 2006 Oct;12(10):1065-72.

16.
17.

High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.

Josting A, Sieniawski M, Glossmann JP, Staak O, Nogova L, Peters N, Mapara M, Dörken B, Ko Y, Metzner B, Kisro J, Diehl V, Engert A.

Ann Oncol. 2005 Aug;16(8):1359-65. Epub 2005 Jun 6.

18.

Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma.

Rapoport AP, Guo C, Badros A, Hakimian R, Akpek G, Kiggundu E, Meisenberg B, Mannuel H, Takebe N, Fenton R, Bolaños-Meade J, Heyman M, Gojo I, Ruehle K, Natt S, Ratterree B, Withers T, Sarkodee-Adoo C, Phillips GL, Tricot G.

Bone Marrow Transplant. 2004 Nov;34(10):883-90.

PMID:
15517008
19.

Partial 7q Isochromosome in Bone Marrow Following Treatment of Hodgkin's Disease.

Grove PS, Auber ML, Wenger SL.

J Assoc Genet Technol. 2003;29(2):64-66.

PMID:
15213420
20.

Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.

Dawson LA, Saito NG, Ratanatharathorn V, Uberti JP, Adams PT, Ayash LJ, Reynolds CM, Silver SM, Schipper MJ, Lichter AS, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):208-18.

PMID:
15093918
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk